High-Quality Selank CAS: 129954-34-3 - Premium Synthetic Peptide from China Suppliers and Factory for Anti-Anxiety Solutions Manufacturers, Quotes
Selank is a synthetic peptide drug, developed by Russian scientists in the 1990s, that is derived from tuftsin, a natural immunomodulatory peptide found in the human body. Recognized for its anti-anxiety properties, Selank offers a promising alternative to traditional benzodiazepines like diazepam, as it avoids common side effects such as sedation, addiction, and cognitive impairment, This innovative peptide operates through a complex mechanism that is not yet fully understood. It modulates the GABA system, the brain's main inhibitory neurotransmitter, and influences the release of endogenous opioid peptides. Additionally, Selank plays a vital role in balancing key neurotransmitters such as serotonin and dopamine, which are essential for mood regulation. Importantly, it also elevates brain-derived neurotrophic factor (BDNF) levels, a crucial component for neuroplasticity and cognitive function, As a leading supplier of Selank, we are committed to providing high-quality synthetic peptides directly from our factory in China. Our products meet stringent quality standards to ensure safety and effectiveness for various applications, including anxiety management and cognitive enhancement. Explore the benefits of Selank and discover why we are trusted suppliers in the peptide industry
Selank is a synthetic peptide drug derived from the natural immunomodulatory peptide tuftsin found in the human body. It was initially developed by Russian scientists in the 1990s as a drug with anti-anxiety effects, but without the sedative, addictive, and cognitive impairment side effects commonly found in traditional benzodiazepines (such as diazepam).
Its mechanism of action is highly complex and not yet fully elucidated, but it is known to work by regulating the GABA system (the brain's primary inhibitory neurotransmitter), influencing the release of endogenous opioid peptides, and modulating the levels of key neurotransmitters such as serotonin and dopamine. Furthermore, Selank can increase the levels of brain-derived neurotrophic factor (BDNF), which is crucial for neuroplasticity and cognitive function.
Therapeutic Areas
Based on preclinical and clinical research, Selank is primarily used in the following therapeutic areas:
Anxiety and Depression Disorders
This is Selank's primary application. It effectively reduces anxiety and tension without causing drowsiness or "mental dullness." It has also been shown to improve mood and alleviate anhedonia (the inability to experience pleasure) in patients with depression accompanied by anxiety.
Cognitive enhancement
Selank is considered a "nootropic drug" or "smart drug." Studies have shown that it can improve learning and memory, enhance concentration, and increase the brain's resistance to stress.
Post-traumatic stress disorder (PTSD)
Due to its powerful anti-anxiety effects and ability to modulate fear memories, Selank has been studied for the treatment of PTSD, helping patients manage hypervigilance and intrusive memories.
Immune system support
Because it is derived from the immune peptide tuftsin, Selank has also been found to have immunomodulatory properties, which can enhance the body's resistance to infection.
Outlook & Development
Selank has a promising future, but it also faces some challenges.
Positive prospects
Excellent safety profile
Compared to current mainstream anti-anxiety medications, Selank's biggest advantage lies in its extremely low incidence of side effects and non-addictive nature. This makes it an ideal candidate for long-term treatment.
Multi-target action
Its complex mechanism of action means that it may have better efficacy for complex diseases accompanied by anxiety.
Nootropic properties
Combining mood improvement with cognitive enhancement makes it uniquely attractive in the field of psychopharmacology, especially for elderly patients or patients with cognitive decline.
The scope of research continues to expand
Scientists are exploring Selank's potential in other areas, such as obsessive-compulsive disorder (OCD), anorexia nervosa, and even as an adjunct treatment for opioid addiction.
Challenges and Development Directions
Regulatory Approval
Currently, Selank is mainly used as a prescription drug in Russia and some CIS countries. It has not yet received approval from the US FDA or the European EMA, which limits its widespread use globally.
Larger-scale clinical trials
To gain international recognition, larger-scale and more rigorous randomized, double-blind, placebo-controlled clinical trials are needed to confirm its efficacy and safety.
In-depth study of the mechanism of action
Although we have a general understanding of its mechanism, the precise molecular pathway still needs to be elucidated, which will help optimize drug design and discover new indications.
Administration routes and formulation improvements
Currently, the most common dosage forms are nasal sprays and injections. Developing more convenient oral formulations or transdermal patches will greatly improve patient medication adherence.
Frequently Asked Questions (FAQ)
What is Selank and where does it come from?
Selank is a synthetic peptide drug derived from tuftsin, a natural immunomodulatory peptide found in the human body. It was initially developed by Russian scientists in the 1990s.
Does Selank cause addiction or sedative side effects?
No. Unlike traditional benzodiazepines, Selank provides anti-anxiety effects without causing sedation, addiction, or cognitive impairment, making it an ideal candidate for long-term treatment.
How does Selank affect the brain?
It regulates the GABA system, influences the release of endogenous opioid peptides, modulates serotonin and dopamine levels, and increases brain-derived neurotrophic factor (BDNF).
What are the primary therapeutic uses of Selank?
Its main applications include treating anxiety and depression disorders, providing cognitive enhancement (as a nootropic), managing PTSD, and offering immune system support.
Is Selank approved by the FDA or EMA?
Currently, Selank has not received approval from the US FDA or the European EMA. It is mainly used as a prescription drug in Russia and some CIS countries.
How is Selank usually administered?
The most common dosage forms are nasal sprays and injections. However, research is ongoing to develop more convenient oral formulations and transdermal patches.
Thin
